CINECA IRIS Institutional Research Information System

PANDOLFI DE RINALDIS, Pier Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.811
EU - Europa 4.392
AS - Asia 2.654
OC - Oceania 16
AF - Africa 15
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.910
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.767
CN - Cina 1.716
IE - Irlanda 756
IT - Italia 674
SE - Svezia 658
DE - Germania 564
FI - Finlandia 454
SG - Singapore 369
UA - Ucraina 353
KR - Corea 324
FR - Francia 251
DK - Danimarca 197
GB - Regno Unito 144
PL - Polonia 135
VN - Vietnam 113
AT - Austria 100
JP - Giappone 34
CA - Canada 32
HK - Hong Kong 22
BE - Belgio 19
ID - Indonesia 19
IN - India 13
NL - Olanda 13
AU - Australia 12
CZ - Repubblica Ceca 12
SN - Senegal 12
GR - Grecia 11
RU - Federazione Russa 11
TW - Taiwan 10
IR - Iran 9
TR - Turchia 9
CH - Svizzera 8
EU - Europa 8
PT - Portogallo 8
NO - Norvegia 7
PR - Porto Rico 6
BR - Brasile 5
PH - Filippine 5
RO - Romania 5
ES - Italia 4
NZ - Nuova Zelanda 4
PE - Perù 4
BG - Bulgaria 3
MY - Malesia 3
PK - Pakistan 3
TH - Thailandia 3
CU - Cuba 2
MX - Messico 2
RS - Serbia 2
AR - Argentina 1
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
LU - Lussemburgo 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
SC - Seychelles 1
SI - Slovenia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 12.910
Salva come PNG Salva come JPEG
Città #
Beijing 1.074
Houston 828
Dublin 755
Chandler 691
Ann Arbor 430
Jacksonville 353
Hangzhou 310
Singapore 273
Torino 272
Ashburn 261
Princeton 230
Fairfield 225
Medford 215
Wilmington 201
Villeurbanne 166
Boston 137
Warsaw 134
Dearborn 117
Woodbridge 108
Vienna 98
Seattle 91
Boardman 84
Dong Ket 65
Nyköping 64
Cambridge 61
San Mateo 55
Milan 46
Fremont 43
Guangzhou 41
Nanjing 40
Norwalk 40
Pisa 38
Falls Church 34
New York 33
Santa Clara 33
Shanghai 31
Turin 30
Düsseldorf 29
Redwood City 28
Washington 25
Hefei 20
Zhengzhou 20
Jakarta 19
Kunming 18
Verona 18
Mountain View 16
Brussels 15
Munich 15
Rome 12
Helsinki 11
San Diego 11
Brno 10
Nürnberg 10
Toronto 10
Jinan 9
Shenzhen 9
Taipei 9
Central District 8
Hong Kong 8
Montréal 8
Phoenix 8
Seoul 8
Nanchang 7
Padova 7
Pune 7
Silver Spring 7
Chongqing 6
Des Moines 6
Fuzhou 6
La Jolla 6
Los Angeles 6
Ottawa 6
Stavanger 6
Wuhan 6
Changsha 5
Chicago 5
London 5
Tappahannock 5
Xian 5
Bologna 4
Chengdu 4
Grafing 4
Mcallen 4
Naples 4
Palaiseau 4
Paris 4
Piura 4
Redmond 4
Secaucus 4
Shenyang 4
Tianjin 4
Upper Marlboro 4
Baltimore 3
Buffalo 3
Central 3
Edinburgh 3
Flushing 3
Fort Worth 3
Freiburg 3
Fucecchio 3
Totale 8.238
Salva come PNG Salva come JPEG
Nome #
Morgana acts as an oncosuppressor in chronic myeloid leukemia. 434
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 322
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology 302
Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs 260
Essential Role of the p110β Subunit of Phosphoinositide 3-OH Kinase in Male Fertility 247
Morgana is a new oncosuppressor in CML 226
Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis 217
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 209
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation 187
An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance 187
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. 158
Generation of Functional Hepatocytes from Mouse Germline Cell-derived Pluripotent Stem Cells in vitro 152
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer 149
Generation of functional multipotent adult stem cells from GPR125+ germline progenitors 148
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer 146
A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells 143
DOK2 inhibits EGFR-mutated lung adenocarcinoma 130
The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo 125
Characterization and Analysis of the Composition and Dynamics of the Mammalian Riboproteome 123
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 119
Pseudogenes as competitive endogenous RNAs: target prediction and validation. 109
The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence. 106
PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity 104
Regulation of the p73 protein stability and degradation. 99
Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway. 97
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia 94
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? 90
A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cell. 89
BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP 87
Role of Dok-1 and Dok-2 in leukemia suppression. 86
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate 83
A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. 83
MORGANA/CHP1 ACTS AS AN ONCOSUPPRESSOR IN CHRONIC MYELOID LEUKEMIA 83
Aberrant mRNA translation in cancer pathogenesis: an old concept revisited comes finally of age. 82
A CK2-dependent mechanism for degradation of the PML tumor suppressor. 81
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion 79
A metabolic prosurvival role for PML in breast cancer. 78
In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes 77
Bone marrow endosteal mesenchymal progenitors depend on HIF factors for maintenance and regulation of hematopoiesis. 76
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events. 76
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation. 75
Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. 75
Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction 74
Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis. 73
Nuclear Akt2 opposes limbal keratinocyte stem cell self-renewal by repressing a FOXO-mTORC1 signaling pathway. 73
Ubiquitination regulates PTEN nuclear import and tumor suppression. 70
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. 69
A novel signal transduction cascade involving directphysical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein 69
Therapeutic inhibition of HAUSP-PTEN network in chronic lymphocytic leukemia 69
Repression of kit expression by Plzf in germ cells. 68
AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions 68
Nucleophosmin serves as a rate-limiting nuclear exportchaperone for the Mammalian ribosome 66
Acetylation-dependent regulation of Skp2 function. 66
The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation 66
A Role for PML in Innate Immunity. 64
A continuum model for tumour suppression 64
The RNA binding protein ESRP1 fine-tunes the expression of pluripotency-related factors in mouse embryonic stem cells 64
PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression 64
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes. 62
Two decades of cancer genetics: from specificity to pleiotropic networks. 62
Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma. 62
Bcr-Abl p210 delocalizes PTEN through a PML/HAUSP network 61
Faithfull Modeling of PTEN Loss Driven Diseases in the Mouse 60
A novel type of cellular senescence that can be enhanced in mousemodels and human tumor xenografts to suppress prostate tumorigenesis 60
The pten–pi3k axis in cancer 60
Mouse modeling in oncologic preclinical and translational research. 60
NGF-promoted axon growth and target innervation requires GITRL-GITR signaling. 59
The theory of APL revisited. 59
EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. 59
Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism 59
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. 58
APL as a paradigm in biomedical research: a journey toward the cure. 58
Subtle variations in Pten dose determine cancer susceptibility 58
The cytoplasmic NPM mutant induces myeloproliferation in atransgenic mouse model 58
The transcription factor Pokemon: a new key player in cancer pathogenesis. 57
Haplo-insufficiency: a driving force in cancer 57
Treatment with 5-azacytidine accelerates acute promyelocytic leukemia leukemogenesis in a transgenic mouse model. 57
Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis 57
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. 56
Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes. 56
TSPYL5 suppresses p53 levels and function by physical interaction with USP7 56
c-Abl phosphorylates Dok1 to promote filopodia during cell spreading. 55
The PTEN-PI3K pathway: of feedbacks and cross-talks 55
Essential role for nuclear PTEN in maintaining chromosomal integrity. 54
The role of PML in the control of apoptotic cell fate: a new key player at ER-mitochondria sites. 54
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis 54
The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. 54
PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR 54
Tsc2-Rheb signaling regulates EphA-mediated axon guidance 54
Ubiquitin-dependent degradation of p73 is inhibited by PML. 53
Deregulated TGF-beta signaling in leukemogenesis. 53
CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor. 52
Breaking the rules of cancer. 52
p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control. 52
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence 52
Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB 51
Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors. 51
The mechanisms of PML-nuclear body formation. 50
Functional Antagonism between Sall4 and Plzf Defines Germline Progenitors 50
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse. 50
Totale 9.331
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.262
article - articoli 0
book - libri 0
conference - conferenze 2.283
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.545
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.125 0 0 0 231 170 640 206 109 275 154 192 148
2020/20211.644 210 47 67 95 163 140 201 39 152 167 152 211
2021/20221.752 62 58 65 197 92 57 180 98 72 99 220 552
2022/20232.336 304 148 44 159 247 667 248 123 222 23 110 41
2023/2024894 130 121 51 58 71 105 22 41 5 31 71 188
2024/2025349 34 186 59 70 0 0 0 0 0 0 0 0
Totale 13.539